Jerome Ritz
#94,158
Most Influential Person Now
Researcher
Jerome Ritz's AcademicInfluence.com Rankings
Jerome Ritzengineering Degrees
Engineering
#2302
World Rank
#3189
Historical Rank
Electrical Engineering
#394
World Rank
#441
Historical Rank
Jerome Ritzcomputer-science Degrees
Computer Science
#3225
World Rank
#3378
Historical Rank
Computational Linguistics
#130
World Rank
#133
Historical Rank
Machine Learning
#328
World Rank
#332
Historical Rank
Artificial Intelligence
#518
World Rank
#527
Historical Rank
Download Badge
Engineering Computer Science
Jerome Ritz's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Jerome Ritz Influential?
(Suggest an Edit or Addition)Jerome Ritz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- An immunogenic personal neoantigen vaccine for patients with melanoma (2017) (1820)
- Biology and clinical relevance of human natural killer cells. (1990) (978)
- Interleukin-2 and regulatory T cells in graft-versus-host disease. (2011) (953)
- Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. (1989) (813)
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial (2018) (754)
- A monoclonal antibody to human acute lymphoblastic leukaemia antigen (1980) (748)
- Activation of a novel human transforming gene, ret, by DNA rearrangement (1985) (743)
- IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. (2006) (725)
- Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression (1979) (582)
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells. (1981) (582)
- The elusive nature and function of mesenchymal stem cells (2011) (572)
- Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. (1997) (551)
- Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer (1991) (491)
- Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. (2005) (450)
- Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors (1990) (445)
- A unique cell surface antigen identifying lymphoid malignancies of B cell origin. (1981) (421)
- Rituximab for steroid-refractory chronic graft-versus-host disease. (2006) (411)
- Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF (1992) (407)
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease (2013) (402)
- Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. (1996) (396)
- Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. (2004) (395)
- Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. (2004) (384)
- CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. (2017) (382)
- Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. (1999) (371)
- Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. (2014) (344)
- Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. (1994) (338)
- Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. (1981) (333)
- TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. (1996) (324)
- Current issues in chronic graft-versus-host disease. (2014) (323)
- Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia (2009) (321)
- Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. (1998) (319)
- ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. (2013) (313)
- A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. (2014) (312)
- A disease risk index for patients undergoing allogeneic stem cell transplantation. (2012) (305)
- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. (2014) (302)
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. (2004) (301)
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. (2009) (300)
- Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. (2013) (291)
- Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. (1987) (291)
- PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. (1999) (291)
- Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein (1985) (286)
- Ipilimumab for Patients with Relapse after Allogeneic Transplantation. (2016) (285)
- Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. (1987) (285)
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. (2017) (270)
- B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. (1997) (267)
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. (2017) (267)
- Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. (1982) (261)
- Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. (2016) (260)
- Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling (1999) (259)
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma (2008) (251)
- Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen. (1987) (250)
- Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. (1985) (247)
- Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. (1983) (239)
- Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia. (1980) (238)
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT (1982) (238)
- Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. (1990) (235)
- High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. (1996) (233)
- SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. (2006) (231)
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. (2010) (223)
- High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease (2007) (223)
- Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. (1996) (222)
- Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. (2005) (219)
- A subset of natural killer cells in peripheral blood displays a mature T cell phenotype (1986) (216)
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. (2016) (213)
- Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. (2000) (211)
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. (2012) (210)
- Phenotypic and functional heterogeneity of human cloned natural killer cell lines (1983) (205)
- Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression (2015) (204)
- Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. (1992) (202)
- Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma. (2017) (198)
- CD3-negative natural killer cells express ε TCR as part of a novel molecular complex (1989) (198)
- High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. (1998) (196)
- Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma (1981) (196)
- Differentiation patterns in the blastic phase of chronic myeloid leukemia. (1983) (196)
- Expression of Common Acute Lymphoblastic Leukemia Antigen (CALLA) by Lymphomas of B-Cell and T-Cell Lineage (1981) (194)
- Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. (2020) (194)
- T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. (2001) (193)
- Characterization of functional surface structures on human natural killer cells. (1988) (192)
- Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. (1985) (189)
- Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. (2006) (186)
- Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation (2004) (181)
- Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion. (1992) (178)
- Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. (2017) (177)
- Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. (1999) (175)
- Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. (1991) (175)
- Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. (1999) (175)
- Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. (2011) (173)
- Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. (2014) (171)
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. (2016) (170)
- Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro. (1980) (164)
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. (2004) (163)
- Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma (2018) (161)
- Probing circulating tumor cells in microfluidics. (2013) (160)
- Establishment of a Ph1-positive human cell line (BV173). (1983) (158)
- Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas (1983) (158)
- Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. (2011) (157)
- Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. (1986) (156)
- Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. (1988) (155)
- Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. (1994) (154)
- Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. (1985) (150)
- Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones. (1985) (150)
- Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity. (2020) (149)
- Specific release of proteoglycans from human natural killer cells during target lysis (1985) (148)
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. (2014) (148)
- Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation (2005) (148)
- Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. (2000) (146)
- Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets. (1981) (145)
- The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. (1999) (145)
- Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells. (1990) (144)
- Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non‐Hodgkin's lymphoma (2002) (141)
- Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. (1981) (140)
- Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD. (2016) (139)
- Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease. (2020) (139)
- Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. (2012) (139)
- Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis (1985) (137)
- Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. (2004) (137)
- Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells (1992) (134)
- Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation. (2007) (134)
- Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells (1994) (130)
- PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. (2017) (128)
- Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. (2000) (126)
- Interleukin 2 signaling involves the phosphorylation of Stat proteins. (1995) (125)
- B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. (2012) (125)
- Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. (1983) (125)
- Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. (2001) (123)
- Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells. (1985) (122)
- Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. (2011) (122)
- Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. (2007) (120)
- Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignancies (1997) (119)
- Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. (1982) (118)
- Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. (1991) (118)
- Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion. (1999) (116)
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. (2016) (116)
- Costimulatory signals are required for optimal proliferation of human natural killer cells. (1993) (116)
- Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function (1983) (115)
- Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis (2011) (113)
- Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. (1990) (112)
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer. (2017) (111)
- Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells. (2016) (110)
- Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial (2017) (109)
- Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation (2009) (108)
- Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. (2006) (108)
- Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. (2002) (107)
- CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia (2001) (106)
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial. (2013) (105)
- NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. (2010) (105)
- PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation. (2018) (104)
- Expression of MY7 antigen on myeloid precursor cells. (1983) (104)
- Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. (1982) (104)
- Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production. (2017) (104)
- Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. (2005) (103)
- Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA) (1983) (102)
- Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. (1995) (101)
- Aberrant B-cell homeostasis in chronic GVHD. (2015) (101)
- Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. (1981) (101)
- Interferon‐γ and interleukin‐4 regulate T cell interleukin‐12 responsiveness through the differential modulation of high‐affinity interleukin‐12 receptor expression (1997) (98)
- Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. (2010) (98)
- Biomanufacturing for clinically advanced cell therapies (2018) (97)
- Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood. (1982) (97)
- IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. (1999) (96)
- Long-Term Follow-up of Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: Prognostic Model to Predict Outcome (2012) (95)
- Circulating T follicular helper cells with increased function during chronic graft-versus-host disease. (2016) (93)
- Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression (2005) (93)
- Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. (1997) (92)
- Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. (2015) (91)
- CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. (2002) (90)
- Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. (1997) (90)
- Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. (1997) (90)
- Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors. (2009) (89)
- Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma. (2002) (89)
- CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. (1997) (89)
- Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. (1995) (87)
- Participation of the CD94 receptor complex in costimulation of human natural killer cells. (1998) (87)
- Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner. (2016) (87)
- MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells (2011) (87)
- Induction of tumor immunity following allogeneic stem cell transplantation. (2006) (87)
- Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. (2004) (87)
- B cells in chronic graft-versus-host disease. (2015) (87)
- Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. (1988) (87)
- Mechanistic approaches for the prevention and treatment of chronic GVHD. (2017) (86)
- Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease (2009) (86)
- Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. (1996) (85)
- CD2 regulates responsiveness of activated T cells to interleukin 12 [published erratum appears in J Exp Med 1995 Oct 1;182(4):1175] (1995) (84)
- Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts. (2012) (84)
- Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation. (1990) (83)
- Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. (1985) (83)
- Prediction of veno-occlusive disease using biomarkers of endothelial injury. (2010) (82)
- Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. (1998) (80)
- In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. (1987) (80)
- Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering (1996) (80)
- Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. (1991) (79)
- Evidence for ineffective erythropoiesis in severe sickle cell disease. (2005) (78)
- Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. (2010) (78)
- Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity (2018) (77)
- Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. (1999) (77)
- A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. (2003) (76)
- Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin. (1997) (76)
- Leukemia-associated antigens in ALL. (1979) (75)
- Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders. (2011) (75)
- T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. (1988) (73)
- Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. (1981) (73)
- Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect (2003) (73)
- Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. (2013) (71)
- Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells (1990) (71)
- Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. (1985) (71)
- Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. (1996) (69)
- Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. (2014) (69)
- Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. (1992) (68)
- Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion (2000) (68)
- In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. (1986) (67)
- Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. (2011) (67)
- Expression of a 26,000-dalton glycoprotein on activated human T cells. (1981) (67)
- Use of Highly Polymorphic DNA Probes for Genotypic Analysis Following Bone Marrow Transplantation (1986) (66)
- Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias. (2017) (65)
- The role of natural killer cells in immune surveillance. (1989) (65)
- Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. (2008) (65)
- Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant (2020) (65)
- Monoclonal Antibody-Purged Autologous Bone Marrow Transplantation Therapy for Multiple Myeloma (1991) (64)
- Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma. (2000) (64)
- Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation (2004) (64)
- Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody. (1981) (63)
- Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts (1983) (62)
- Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. (1984) (62)
- CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice (2016) (61)
- Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. (1991) (60)
- A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL (2010) (60)
- Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. (1998) (60)
- A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation. (2008) (60)
- Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. (2002) (60)
- Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation. (2009) (60)
- Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. (1998) (60)
- Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. (2011) (58)
- Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis (2007) (57)
- Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation. (1986) (57)
- Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells. (2010) (57)
- Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells (2005) (57)
- HEPATIC DYSFUNCTION FOLLOWING T‐CELL-DEPLETED ALLOGENEIC BONE MARROW TRANSPLANTATION (1991) (56)
- Epstein‐Barr virus‐specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma (2017) (56)
- Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage. (1992) (56)
- The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. (1985) (56)
- Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies (1993) (54)
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. (2016) (53)
- Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD (2013) (52)
- Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. (1987) (52)
- Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12. (1998) (52)
- ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction (2002) (51)
- CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. (2001) (51)
- Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. (1991) (50)
- Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism (2000) (50)
- FcγRIIIA-mediated signaling involves src-family lck in human natural killer cells (1993) (50)
- Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism (2000) (50)
- Enhancement of natural killer function through activation of the T11 E rosette receptor. (1987) (50)
- The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. (1994) (49)
- Next‐generation sequencing‐based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma (2016) (49)
- Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion. (2003) (48)
- Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. (1996) (48)
- Expression of CD30 in patients with acute graft-versus-host disease. (2012) (48)
- Human leukemia-associated antigen: relation to a family of surface glycoproteins. (1980) (48)
- Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors. (1981) (47)
- Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning. (2009) (47)
- Induction of natural killer effectors from human thymus with recombinant IL-2. (1988) (47)
- Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. (1981) (47)
- Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. (1981) (47)
- Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells. (1994) (47)
- Immune‐Mediated Cytopenia following Bone Marrow Transplantation Case Reports and Review of the Literature (1992) (47)
- IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops (1998) (47)
- An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. (2017) (46)
- Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation (2017) (46)
- Identification of a 140‐kDa activation antigen as a target structure for a series of human cloned natural killer cell lines (1984) (45)
- Function of the LFA‐1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes (1986) (44)
- Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation (2016) (43)
- A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. (2014) (43)
- Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. (1993) (43)
- A Novel Mechanism of Alternative Promoter and Splicing Regulates the Epitope Generation of Tumor Antigen CML66-L1 (2004) (43)
- Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease. (2014) (42)
- Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation. (2009) (42)
- Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia (1993) (41)
- Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival. (2014) (41)
- Generation of Monoclonal Antibodies to a Human Natural Killer Clone (41)
- Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. (2001) (41)
- Factors associated with bronchiolitis obliterans syndrome and chronic graft‐versus‐host disease after allogeneic hematopoietic cell transplantation (2014) (41)
- Allogeneic stem cell transplantation for multiple myeloma. (2002) (40)
- Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function. (1989) (40)
- Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component. (1997) (40)
- Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy. (2018) (40)
- Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2. (1996) (40)
- Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host-disease. (2020) (39)
- Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. (1981) (39)
- Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses (2018) (39)
- Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma. (1997) (39)
- Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation. (2019) (39)
- Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. (2011) (39)
- Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. (1996) (39)
- CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin’s lymphoma (1998) (38)
- Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation. (1998) (38)
- Current challenges in chronic graft-versus-host disease. (2010) (38)
- Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. (1986) (38)
- Validation of short‐term handling and storage conditions for marrow and peripheral blood stem cell products (2011) (37)
- Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells. (1995) (37)
- Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. (2008) (37)
- Autoimmune pancytopenia following allogeneic bone marrow transplantation. (1990) (37)
- Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome. (2015) (36)
- Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation (2021) (36)
- Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients. (1989) (36)
- Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide. (2021) (36)
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction. (2009) (35)
- Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. (1991) (35)
- Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells. (2012) (35)
- Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells. (1989) (34)
- Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion (2010) (34)
- Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. (2010) (34)
- Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes (2010) (34)
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Dose Intensification With Granulocyte Colony-Stimulating Factor Markedly Depletes Stem Cell Reserve for Autologous Bone Marrow Transplantation (1997) (34)
- CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. (1997) (33)
- A multicenter, phase I study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation. (2020) (33)
- CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. (1997) (33)
- Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation. (2018) (33)
- PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation. (2018) (33)
- Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease. (2015) (33)
- Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma (2016) (32)
- Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells. (1996) (32)
- Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target. (2014) (32)
- Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response (2018) (31)
- Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT (2014) (31)
- Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. (2002) (31)
- Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphoma. (2002) (30)
- Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. (1986) (30)
- Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children. (2019) (30)
- ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications. (2006) (30)
- Use of the immunotoxin N901‐blocked ricin in patients with small‐cell lung cancer (1994) (29)
- Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines (2015) (29)
- Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity (2021) (29)
- Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities (2015) (28)
- Mechanism of EBV inducing anti-tumour immunity and its therapeutic use (2020) (28)
- Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)- positive fetal bone marrow cells (1987) (28)
- Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease. (1992) (28)
- Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity (1986) (28)
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. (2015) (28)
- A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells. (2001) (28)
- Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. (1990) (27)
- Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion (1992) (27)
- Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation. (2003) (26)
- Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results (2018) (26)
- In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. (1986) (25)
- Dramatic Expansion of HSCs: New Possibilities for HSC Transplants? (2016) (24)
- KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation (2013) (24)
- In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool. (1985) (23)
- Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease. (2019) (23)
- Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia (2019) (23)
- Low dose interleukin‐2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission (2008) (22)
- Identification of Cytolytic CD161−CD56+ Regulatory CD8 T Cells in Human Peripheral Blood (2013) (22)
- Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation (2010) (22)
- Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. (1993) (22)
- Research Techniques Made Simple: Experimental Methodology for Single-Cell Mass Cytometry. (2017) (21)
- CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells. (2001) (21)
- Bayesian Error‐in‐Variable Survival Model for the Analysis of GeneChip Arrays (2005) (21)
- Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia. (1994) (21)
- Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans. (2011) (21)
- Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease. (2019) (21)
- Combined CD4 T-Cell and Antibody Response to Human Minor Histocompatibility Antigen DBY After Allogeneic Stem-Cell Transplantation (2011) (21)
- CD2‐CD58 Interaction and the Control of T‐Cell Interleukin‐12 Responsiveness (1996) (21)
- A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation (2016) (21)
- Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model. (1990) (20)
- IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults (2015) (20)
- Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma (2018) (20)
- Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. (2012) (20)
- PERSISTENCE OF MYELOID PROGENITOR CELLS EXPRESSING BCR-ABL MRNA AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (1994) (20)
- Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD (2013) (19)
- Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation. (1983) (19)
- Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells. (1989) (19)
- CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation. (2006) (19)
- Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation. (1995) (19)
- Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse (2022) (19)
- FT1050 (16,16-dimethyl Prostaglandin E2)-Enhanced Umbilical Cord Blood Accelerates Hematopoietic Engraftment After Reduced Intensity Conditioning and Double Umbilical Cord Blood Transplantation (2011) (19)
- Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia (2022) (18)
- Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents. (1994) (18)
- Evidence against T‐cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression (1996) (18)
- A Multicenter Phase I Study of CTLA-4 Blockade with Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (2014) (18)
- Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies. (1981) (18)
- Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation. (1996) (18)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report. (2021) (17)
- Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease. (2019) (17)
- Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT. (2017) (17)
- Early neutrophil engraftment following autologous BMT provides a functional predictor of long‐term hematopoietic reconstitution (2003) (17)
- Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation (2008) (17)
- Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis. (2007) (17)
- Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele. (1988) (17)
- Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia. (2020) (17)
- Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma. (1990) (17)
- A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis. (2018) (17)
- White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome (2014) (17)
- Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells. (1993) (17)
- Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease. (2017) (16)
- Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure. (1984) (16)
- Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial. (2018) (16)
- Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture. (1985) (16)
- Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation (2014) (16)
- The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia. (1990) (16)
- Tregs, HSCT, and acute GVHD: up close and personal. (2013) (15)
- Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease (2019) (15)
- Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (2017) (15)
- Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis. (2007) (15)
- FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia (2005) (15)
- Detecting T-cell reactivity to whole cell vaccines (2012) (15)
- Flipping the Switch: Initial Results of Genetic Targeting of the Fetal to Adult Globin Switch in Sickle Cell Patients (2018) (15)
- A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT) (2016) (15)
- Impact of diagnostic genetics on remission MRD and transplantation outcomes in older AML patients. (2022) (15)
- Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines. (1986) (15)
- Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients. (2017) (14)
- Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. (1994) (14)
- Fc, receptor type III (CD16) is included in the ; NK receptor complex expressed by human natural killer cells (14)
- Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease (2019) (14)
- Quantitative Monitoring of BCR / ABL Transcript During STI-571 Therapy (2002) (14)
- Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors. (2002) (14)
- Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway (2016) (14)
- Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation. (1997) (13)
- Application of Monoclonal Antibodies to Autologous Bone Marrow Transplantation (1984) (13)
- Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results. (1993) (13)
- Research Techniques Made Simple: Mass Cytometry Analysis Tools for Decrypting the Complexity of Biological Systems. (2017) (13)
- Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation. (1986) (13)
- Human cell lines express multiple populations of Ia-like molecules. (1981) (13)
- A first-in-human phase I trial of NKG2D chimeric antigen receptor-T cells in AML/MDS and multiple myeloma. (2016) (13)
- Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease. (2013) (13)
- Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation (2021) (13)
- Effect of sirolimus on immune reconstitution following myeloablative allogeneic stem-cell transplantation: An ancillary analysis of a randomized controlled trial comparing Tacrolimus/Sirolimus with Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402). (2019) (12)
- A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (2013) (12)
- Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution (2021) (12)
- Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation. (2008) (12)
- Monoclonal antibodies: their use in bone marrow transplantation. (1987) (12)
- R24 anti‐GD3 ganglioside antibody can induce co‐stimulation and prevent the induction of alloantigen‐specific T cell clonal anergy (1996) (12)
- Sequential infusion of donor‐derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation (2014) (12)
- In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation. (1997) (12)
- PD-1 Signaling Has a Critical Role in Maintaining Regulatory T Cell Homeostasis; Implication for Treg Depletion Therapy By PD-1 Blockade (2015) (12)
- Gene Therapy Using a Self-Inactivating Lentiviral Vector Improves Clinical and Laboratory Manifestations of Wiskott-Aldrich Syndrome (2015) (11)
- Adult hematopoietic stem cell plasticity (2002) (11)
- A Multicenter Phase I/Ib Study of Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (11)
- Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy (2004) (11)
- Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy (2020) (11)
- Clonal evidence for the induction of NKH1 on activated human thymocytes (1989) (11)
- Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions (2014) (11)
- A clonal model for human CD8+ regulatory T cells: Unrestricted contact‐dependent killing of activated CD4+ T cells (2012) (11)
- Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin (2005) (10)
- Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity (2020) (10)
- Monoclonal antibody purged autologous bone marrow transplantation for relapsed non i acute lymphoblastic leukemia (1985) (10)
- Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome (2014) (10)
- Inhibition of Inositol kinase B controls acute and chronic graft-versus-host disease. (2019) (10)
- Low-dose Interleukin-2 in the Treatment of Autoimmune Disease (2014) (10)
- Revealing Tumor Immunity after Hematopoietic Stem Cell Transplantation (2009) (9)
- Time to put the CAR-T before the horse. (2011) (9)
- B-cell-directed therapy for chronic graft-versus-host disease (2010) (9)
- Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation (2021) (9)
- BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation. (2016) (9)
- Imatinib Therapy for Patients with Chronic Myelogenous Leukemia (2004) (9)
- Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect (2020) (9)
- Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation (2022) (9)
- Engineered Memory-like NK Cars Targeting a Neoepitope Derived from Intracellular NPM1c Exhibit Potent Activity and Specificity Against Acute Myeloid Leukemia (2020) (9)
- NKTR-358: A novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases (2021) (9)
- The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation. (1994) (9)
- Targeting PI3Kδ function for amelioration of murine chronic graft‐versus‐host disease (2019) (8)
- Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation. (1997) (8)
- Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform (2021) (8)
- Epstein-Barr Virus-Transformed B-Cell Line (DV-1) Derived from Bone Marrow of a Patient with Severe Combined Immunodeficiency and Immunoblastic Lymphoma (1987) (8)
- Interferon-induced changes in expression of antigens defined by monoclonal antibodies on malignant and nonmalignant mononuclear hematopoietic cells. (1983) (8)
- Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood. (1987) (7)
- Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation (2012) (7)
- Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. (1995) (7)
- Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells. (2019) (7)
- Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib (2015) (7)
- Ultrastructural evidence that the granules of human natural killer cell clones store membrane in a nonbilayer phase. (1987) (7)
- Outcomes of Severe Combined Immunodeficiency Patients Treated with Hematopoietic Stem Cell Transplantation with and without Pre-conditioning (2012) (7)
- Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation. (2008) (7)
- Autologous Bone Marrow Transplantation in Calla Positive Acute Lymphoblastic Leukemia (1984) (6)
- The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome (2018) (6)
- Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement. (1986) (6)
- In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia. (1983) (6)
- Clonal Hematopoiesis Associated with Adverse Outcomes Following Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma (2016) (6)
- Cell-Surface Antigens in Acute Leukemia (1982) (6)
- Autologous bone marrow transplantation therapy for multiple myeloma (1989) (6)
- A chronic “postinfectious” fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6 (1990) (6)
- T-cell clonal dynamics determined by high resolution TCR-β sequencing in recipients after allogeneic hematopoietic cell transplantation. (2020) (6)
- Safety and Efficacy of Allogeneic Hematopoetic Stem Cell Transplant (HSCT) after Treatment with Programmed Cell Death 1 (PD-1) Inhibitors (2015) (6)
- Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes (2016) (6)
- Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations. (1995) (6)
- DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant (2020) (6)
- Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells (cTFR) and Suppresses Circulating T Follicular Helper Cells (cTFH) in Patients with Chronic Gvhd (2018) (6)
- Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study (2019) (6)
- Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation (2022) (5)
- Targeting BCL6 and Germinal Centers (GCs) in Chronic Graft-Versus-Host Disease (cGVHD) Using Direct and Epigenomic Therapies (2014) (5)
- A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation (2019) (5)
- Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias (2021) (5)
- PD-1 modulates regulatory T cell homeostasis during low-dose IL-2 therapy (2017) (5)
- Alterations in Ca2+ signal transduction in critically ill surgical patients. (1994) (5)
- A Phase I Study of Lenalidomide in Combination with Fludarabine-Rituximab in Previously Untreated CLL/SLL. (2009) (5)
- Genomic analysis in lymphoid leukemias. (2005) (5)
- Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses (2021) (5)
- Studying Human Regulatory T Cells In vivo (2006) (5)
- Clinical Applications of Monoclonal Antibodies in Acute Leukemia a (1984) (5)
- High Levels of Early Donor Chimerism and Treatment-Responsive Disease Predict Improved Progression-Free Survival Following Non-Myeloablative Transplantation for Advanced CLL. (2005) (5)
- Lymphoma with clonal T‐cell receptor gene rearrangement in a 25‐year survivor of Hodgkin's disease (1987) (5)
- Autologous Peripheral Blood Stem Cell Products from Patients with Hematologic Malignancies Have Increased Frequency of Regulatory T Cells (CD4+FoxP3+ Treg). (2008) (5)
- Cell-free DNA Tissues-of-Origin Profiling to Predict Graft versus Host Disease and Detect Infection after Hematopoietic Cell Transplantation (2020) (4)
- Cytokine-Induced Memory-like NK Cells Exhibit Massive Expansion and Long-Term Persistence after Infusion Post-Haploidentical Stem Cell Transplantation: A Report of the First Three Cases in a Phase I Trial (2020) (4)
- Genome Wide Single Nucleotide Polymorphism Typing for Identification of Putative Minor Histocompatibility Antigens in Graft Versus Host Disease. (2006) (4)
- Prophylactic Rituximab After Allogeneic Stem Cell Transplantation Prevents Steroid-Requiring Chronic Graft-Vs.Host Disease (2010) (4)
- KIR-Ligand Incompatibility Is Not Associated with Relapse Reduction After Double Umbilical Cord Blood Transplantation, (2011) (4)
- BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. (2022) (4)
- Pre-Infusion Characteristics of the Predominant Cord Blood Unit Correlate with Hematopoietic Engraftment in the Setting of Non-Myeloablative Double Cord Blood Transplant (DCBT). (2005) (4)
- Sirolimus, Tacrolimus and Reduced-Dose Methotrexate as Graft Versus Host Disease (GVHD)Prophylaxis after Non-Myeloablative Stem Cell Transplantation: Low Incidence of Acute GVHD Compared with Tacrolimus/Methotrexate or Cyclosporine/Prednisone. (2004) (4)
- CD 6-Depleted Allogeneic Bone Marrow Transplantation for Acute Leukemia in First Complete Remission (1997) (4)
- Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation (2021) (4)
- Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia. (2008) (4)
- Transcript Synthesis and Surface Expression of the Interleukin-2 Receptor ( a-, p-, and ?-Chain ) by Normal and Malignant Myeloid Cells (2002) (4)
- Reprint of: B cells in chronic graft-versus-host disease. (2015) (4)
- Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements (2011) (4)
- A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease (2022) (4)
- Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces. (1991) (4)
- Ia DETERMINANTS ON H U M A N T-CELL SUBSETS DEFINED BY MONOCLONAL ANTIBODY (2003) (3)
- Chronic GvHD NIH Consensus Project Biology Task Force: Evolving path to personalized treatment of chronic GvHD. (2022) (3)
- Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease (2022) (3)
- Antigen targets of remission-inducing immune therapy are expressed on CML progenitor cells (2010) (3)
- Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders. (2009) (3)
- A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL. (2010) (3)
- Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease (2017) (3)
- Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults. (2017) (3)
- Up-Regulation of α 4 β 7 Integrin on Peripheral T Cell Subsets Correlates with the Development of Acute Intestinal Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation (2010) (3)
- Abstract 2954: Immunomodulator maintenance post autologous stem cell transplant predicts better outcome in multiple myeloma patients with clonal hematopoiesis of indeterminate potential (2018) (3)
- Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation. (2007) (3)
- Immune reconstitution after allogeneic stem cell transplantation. (2005) (3)
- Itolizumab As a Potential Therapeutic for the Prevention and Treatment of Graft Vs Host Disease (2019) (3)
- Immunomodulatory effects of donor lymphocyte infusions following allogeneic bone marrow transplantation (1995) (3)
- Genetic Screening for Myeloma Cell Susceptibility to NK Cell Mediated Lysis Using Large Lentiviral shRNA Libraries (2008) (3)
- Ex Vivo Treatment of Hematopoietic Stem Cells With 16,16-Dimethyl Prostaglandin E2 (FT1050) Improves Engraftment and Hematopoietic Reconstitution (2011) (3)
- A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation (2019) (3)
- Recipient T-Cell Repertoire Diversity after Double Umbilical Cord Transplantation Correlates with Non-Relapse Mortality and Survival (2014) (3)
- GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial (2021) (3)
- Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with and without pembrolizumab maintenance therapy in patients with lymphoma. (2021) (3)
- Rituxan for steroid-refractory chronic GVHD (2005) (3)
- Impact Of Umbilical Cord Unit Banking Conditions On Clinical Outcomes In Double Cord Transplant Recipients (2013) (3)
- graft-versus-host disease Altered B-cell homeostasis and excess BAFF in human chronic (2009) (3)
- Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy (2021) (3)
- Prognostic significance of the surface antigens expressed by leukemic cells. (1994) (3)
- Abstract 5631: Personal neoantigen-targeting vaccination generates neoepitope-specific T cell responses in tumors of patients with glioblastoma (2018) (3)
- Transplantation with anti-B1 monoclonal antibody and complement treated autologous bone marrow for relapsed B-cell non-Hodgkin’s lymphoma (1985) (3)
- High Levels of Donor Chimerism Early after Non-Myeloablative Transplantation Predictive of Overall and Progression Free Survival but Not Risk of Acute Graft Versus Host Disease for Patients with AML or MDS. (2004) (2)
- Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. (1993) (2)
- Comparative analysis of cell therapy infusion workflows at clinical sites. (2021) (2)
- Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model (2013) (2)
- Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56bright NK Cells in Patients with Chronic Gvhd (2018) (2)
- 1022 A LYMPHOBLASTOID B-CELL LINE (LBL) DERIVED FROM A 12-YEAR-OLD BOY WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID) (1985) (2)
- TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant (2014) (2)
- Evidence for Ineffective Erythropoiesis in Patients with Severe Sickle Cell Anemia. (2004) (2)
- 31: Comprehensive Typing of 1143 Single Nucleotide Polymorphisms (SNP) in 220 Immunoregulatory Genes Demonstrates That Polymorphisms in CCL3, CCL4 and CCL27 Modulate the Risk of Acute Graft Versus Host Disease (GVHD) (2008) (2)
- Phase I Multicenter Trial of Brentuximab Vedotin for Steroid Refractory Acute Graft-Vs.-Host Disease (GVHD) (2016) (2)
- NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation. (2018) (2)
- Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia. (1994) (2)
- Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease (2019) (2)
- NK-Associated and LFA-1 Antigens: Phenotypic and Functional Studies Utilizing Human NK Clones (1986) (2)
- Immunoproteomic Identification of Graft-Versus-Leukemia Targets in Patients with Chronic Lymphocytic Leukemia. (2007) (2)
- A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones [retracted by Reinherz EL. In: J Exp Med 1987 Jan 1;165(1):275] (1986) (2)
- Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease (2019) (2)
- Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant naïve settings. (2022) (2)
- Rituximab Therapy for Steroid-Refractory Chronic GVHD: Safety and Efficacy Analysis. (2004) (2)
- NK cell cytokine secretion regulated by SHIP1 (2005) (2)
- CD25+ Regulatory T CELL-Depleted Donor Lymphocyte Infusion for Relapse After Allogeneic Transplantation – A PHASE 1 Study (2013) (2)
- Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8+T Cells. (2007) (2)
- Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies (2021) (2)
- Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation (2007) (2)
- transplantation in adults depends on reconstitution of thymopoiesis Clearance of CMV viremia and survival after double umbilical cord blood (2013) (2)
- IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy (2015) (2)
- Impact of Cytogenetics and Prior Therapy on Outcome of AML and MDS after Allogeneic Transplantation. (2006) (2)
- Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib (2018) (2)
- Sequencing-Based Detection of Circulating Tumor DNA in the Autologous Stem Cell Grafts of Patients with Diffuse Large B-Cell Lymphoma Undergoing Hematopoietic Stem Cell Transplantation (2015) (2)
- Genetic Predispositions, Management Strategies, and Clinical Outcomes in Adults with Hemophagocytic Lymphohistiocytosis (HLH) after Reduced-Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation (HSCT) at Dana-Farber Cancer Institute (2019) (2)
- CD 95-Mediated Calcium S ignaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice Graphical (2016) (2)
- Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) (2004) (2)
- Immune Reconstitution and Preliminary Safety Analysis Of 9 Patients Treated With Somatic Gene Therapy For X-Linked Severe Combined Immunodeficiency (SCID-X1) With a Self-Inactivating Gammaretroviral Vector (2013) (2)
- Improved Immune Reconstitution After Bortezomib-Based Acute Graft-Versus-Host Disease Prophylaxis for HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Allogeneic Transplantation. (2009) (2)
- Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease. (2023) (2)
- Expression of α4β7 Integrin on Memory CD8+ T-Cells Is Increased in Patients at Presentation of Acute Intestinal Graft-Vs-Host Disease (2012) (2)
- Genetic Ontogeny Defines Distinct Prognostic Subgroups in AML Patients Age 60 and Older Following Hematopoietic Stem Cell Transplantation (2017) (2)
- Impact Of Total Nucleated Cell and CD34+ Cell Dose On Transplant Related Outcomes In Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplants (2013) (2)
- Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement. (1988) (2)
- Expansion, persistence and efficacy of donor memory-like NK cells for the treatment of post-transplant relapse (2021) (1)
- Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (2014) (1)
- IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets (2015) (1)
- Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation (2019) (1)
- Ex Vivo Treatment of Human Cord Blood with dmPGE2 Can Safely Increase the Potential for Hematopoietic Engraftment. (2007) (1)
- Prediction of VOD Using Biomarkers of Endothelial Injury (2009) (1)
- Decreased Telomerase Activity In CD4 Regulatory T Cells Is Associated with Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT) (2010) (1)
- A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival (2011) (1)
- Feasibility, Safety, Efficacy And Immunologic Impact Of Daily Ultra-Low-Dose Interleukin-2 For Steroid-Refractory Chronic Graft-Versus-Host Disease: A Phase I Study (2010) (1)
- Functional surface structures on human natural killer cells (1985) (1)
- Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease (2022) (1)
- ORIGINAL ARTICLE Expression of a4b7 integrin on memory CD8 þ T cells at the presentation of acute intestinal GVHD (2013) (1)
- Reconstitution of T Cell Immunity after Umbilical Cord Blood Transplantation. (2015) (1)
- A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results (2013) (1)
- Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection. (1998) (1)
- Genetic Disparity between Stem Cell Transplant Patients and Their Donors Assessed by High Density Single Nucleotide Polymorphism (SNP) Microarray Typing Is Seen in Specific Genomic Regions. (2004) (1)
- PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation (2018) (1)
- Brief Definitive Report a Lymphokine That Activates the Cytolytic Program of Both Cytotoxic T Lymphocyte and Natural Killer Clones (2003) (1)
- antileukemia responses to donor lymphocyte infusion Reversal of in situ T-cell exhaustion during effective human (2014) (1)
- Chronic GVHD Is Associated with a BAFF Driven BCR-Activated B Cell Repertoire. (2007) (1)
- Response to Helsby and Tingle (2011) (1)
- Mixed Chimerism Following Nonmyeloablative Stem Cell Transplantation for Sickle Cell Disease Prevents Intravascular Hemolysis and Restores Endothelial Function. (2004) (1)
- depleted allogeneic bone marrow transplantation Effect of low-dose interleukin-2 on disease relapse after T-cell- (2011) (1)
- Abstract 2591: Ibrutinib can reverse established chronic graft-versus-host disease, which is dependent upon IL-2 inducible T-cell kinase (ITK) and Bruton's tyrosine kinase (BTK)-driven lymphocyte activation (2014) (1)
- 34: Characterization of B Cell Target Antigens in Patients with Chronic Graft Versus Host Disease (2008) (1)
- Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation (2019) (1)
- Evolution of T Cell Repertoire Diversity After Reduced-Intensity Conditioning and Double Umbilical Cord Blood Transplantation with or without Exposure to FT1050 (16,16-dimethyl Prostaglandin E2) (2013) (1)
- Enhancement of Tumor Cell Susceptibility to NK Cell Activity Through Inhibition of the PI3K Signaling Pathway. (2012) (1)
- Increased Naive, Stem Cell Memory and Terminally Differentiated CD8+ T Cells in Chronic Graft Versus Host Disease (2017) (1)
- Expression of Normal Differentiation Antigens on Human Leukemias and Lymphomas (1983) (1)
- Longitudinal Changes in the Intestinal Microbiome Composition Following Gut Decontamination in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients: A Pilot Study (2019) (1)
- Assessment of a Multi-Cytokine Profile By a Novel Biochip-Based Assay Reveals Unique Correlation Patterns with Immune Reconstitution after Cord Blood Transplantation in Adults (2017) (1)
- BAFF/Blys Levels Correlate with Disease Activity and Alter Peripheral B Cell Subsets in Patients with Chronic GVHD. (2006) (1)
- DAPK2 and PIM1 Are Myeloma-Associated Antigens That Elicit Coordinated B and T Cell Immunity After Syngeneic HSCT. (2009) (1)
- Abstract LB-272: T-cell clonal dynamics determined by high resolution TCR-β sequencing in recipients of allogeneic hematopoietic cell transplantation (2020) (1)
- A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease (2013) (1)
- Low-Dose IL-2 Induces Bcl2 Expression and Resistance To Apoptosis In CD4 Regulatory T Cells (2013) (1)
- Effective Graft-Versus-Leukemia Responses To Donor Lymphocyte Infusion Are Associated With Preexisting CD8+T Cell Marrow Infiltrates (2010) (1)
- Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial (2016) (1)
- Immunomodulatory therapy improves outcome in multiple myeloma patients with clonal hematopoiesis (2019) (1)
- Graft-Versus-Leukemia Antigen CML66 Elicits Coordinated B and T Cell Immunity After Donor Lymphocyte Infusion. (2009) (1)
- Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells (2008) (1)
- Activation of natural killer function through the T11/E rosette receptor. (1987) (1)
- Durability of clinical and immunologic responses to extended low-dose interleukin-2 therapy in patients with refractory chronic graft-versus-host disease (2022) (1)
- Reduced Intensity Conditioning (RIC) with Double Umbilical Cord Blood Transplantation Has Similar Outcomes Compared to RIC Transplantation From Related or Unrelated Adult Donors (2010) (1)
- Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation (2022) (1)
- Donor Chip Causes Donor-Derived Clonal Hematopoiesis As an Early Complication of Allogeneic Stem Cell Transplantation (2016) (1)
- CD95 recruits PLCγ1 to trigger a calcium response promoting Th17 accumulation in inflamed organs of lupus mice (2016) (1)
- Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell Transplantation (2020) (1)
- Interval of IL-2 Administration Has a Major Impact on Treatment Efficacy for Regulatory T Cell Expansion and Homeostasis (2015) (1)
- The expression of interleukin-2 receptor subunits on the different human peripheral blood mononuclear cell subsets displays a highly sensitive profile (1997) (1)
- Common gamma-chain signaling is sufficient to prevent alloantigen specific T-cell clonal anergy (1994) (1)
- Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem-Cell Transplantation: A Post-Hoc Analysis of a Randomized Controlled Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate (BMT CTN 0402) (2018) (1)
- All-Trans Retinoic Acid (ATRA) Targets IRF4 Deficient, NOTCH2-Activated B Cells from Chronic Gvhd Patients (2016) (1)
- T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy (2017) (1)
- Monoclonal antibody (McAb) purged autologous bone marrow transplantation (ABMTx) for relapsed non t-cell acute lymphoblastic leukemia (ALL) (1986) (1)
- Dynamics of Immune Cell Reconstitution in Allogeneic Hematopoietic Cell Transplant Patients Receiving Post-Transplant Cyclophosphamide (PTCy) (2019) (1)
- Abstract CT540: A phase 1 trial of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy with IL-15 superagonist in advanced head and neck cancer: Part 1 results (2022) (1)
- Infusion of CD 4 Donor Lymphocytes Induces the Expansion of CD 8 Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells 1 (2002) (1)
- Serotherapy and Bone Marrow Transplantation (1985) (1)
- Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens. (2007) (1)
- Early Post-Transplant Whole Tumor Cell Vaccination Elicits Anti-Tumor T Cell Responses in Patients With Advanced Chronic Lymphocytic Leukemia (CLL) (2011) (1)
- Personnel environmental monitoring during manufacture of manipulated cell therapy products (2018) (1)
- Trans-presentation of IL-15 (2006) (1)
- JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression (2013) (1)
- Markedly Reduced Overall Survival of CYP2C19 *2/*2 Homozygotes After Myeloablative Hematopoietic Stem Cell Transplantation (2010) (1)
- Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation (2011) (0)
- Pre and Post-Treatment CD27+ T Cells Track with Clinical Efficacy of Axi-Cel in DLBCL Patients (2022) (0)
- Defective populations of regulatory T cells correlate with the occurrence of chronic graft versus host disease after allogeneic stem cell transplantation (2004) (0)
- lymphocytes from patients with hematologic and solid malignancies Interleukin-12 augments cytolytic activity of peripheral blood (2011) (0)
- Targets ofTumor ImmunityAfterAllogeneic Hematopoietic Stem (2008) (0)
- for children with recurrent acute lymphoblastic leukemia Autologous bone marrow transplantation after a long first remission (2011) (0)
- in the Treatment of Leukemia and Lymphoma (2016) (0)
- The Y-Specific Gene PRY Is Expressed in Normal Blood Cells as Well as Leukemia Cells and Can Elicit a Specific Antibody Response in Male Recipients of Hematopoietic Stem Cells from Female Donors. (2004) (0)
- Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia (2020) (0)
- concentrations (see comments) Recombinant interleukin-2 infusions and decreased IgG2 subclass (2011) (0)
- Author Correction: Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias (2021) (0)
- Acute Lymphoblastic Leukemia Autologous Versus Unrelated Donor Allogeneic Marrow Transplantation for (2011) (0)
- Outcomes of 48 Severe Combined Immunodeficiency Patients Treated with Hematopoietic Stem Cell Transplantation at a Single Center Between 1981 and 2007 (2009) (0)
- TRANSPLANTATION Ef fi cacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease (2016) (0)
- Myeloablative Flu/Bu Conditioning Provides Similar Overall Survival and Lower Non-Relapse Mortality Compared to Traditional Bu/Cy or Cy/TBI in Allogeneic Transplantation (2017) (0)
- Ex Vivo Treatment of Umbilical Cord Blood with Prostaglandin E2 Alters the Molecular and Functional Properties of T Cells Via Modulating Wnt/β-Catenin Signaling (2013) (0)
- Generation of Tumor Antigen CML66-L and Splicing Regulates the Epitope A Novel Mechanism of Alternative Promoter (2013) (0)
- 801 ABSENCE OF COMMON ALL ANTIGEN ON NORMAL PLURIPOTENTIAL MYELOID, ERYTHROID AND GRANULOCYTE PROGENITORS (1981) (0)
- Use of Monoclonal Antibodies as Diagnostic and Therapeutic Reagents in Acute Lymphoblastic Leukemia 1 (2006) (0)
- NOVEL Pathways Modulate TUMOR CELL Susceptibility to NK CELLS. (2009) (0)
- Apoptotic Pathways of Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (2012) (0)
- Abstract 3371: Mapping the evolution of T cell states during DLI response and resistance using single-cell data and computational tools (2019) (0)
- Low-Dose IL-2 Reduces Mitochondrial Priming and Increases Bcl2 Expression in CD4 Memory Regulatory T Cells (2014) (0)
- NK Cell Impairment after Haploidentical Allogeneic Hematopoietic Cell Transplant in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) (2020) (0)
- cells from normal human bone marrow Purification of common acute lymphoblastic leukemia antigen positive (2011) (0)
- Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS (2022) (0)
- IMMU-23. IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL AND ASSESSING CLONAL T CELL RESPONSE. (2017) (0)
- transplantation and primary biliary cirrhosis hematologic malignancies after allogeneic hematopoietic stem cell Differential epitope mapping of antibodies to PDC-E2 in patients with (2013) (0)
- Therapeutic treatment of multi-organ system, obstructive pulmonary and scleradermatous chronic graft-versus-host disease with the BTK and ITK inhibitor Ibrutinib (TRAN3P.873) (2014) (0)
- Ex Vivo Expansion of Donor-Derived Anti-Tumor T Cells for CLL-Specific Adoptive Immunotherapy (2011) (0)
- Allogeneic Stem Cell Cryopreservation Is Associated with Equivalent Survival and Relapse Rates with Lower Rate of Severe Chronic Gvhd (2022) (0)
- Factor VIII is a potential autosomal B cell minor histocompatibility antigen in chronic GVHD (2010) (0)
- Prognostic Value of TREC, IL-7 and SCF Levels on Clinical Outcomes after Double Umbilical Cord Blood Transplantation in Adults (2014) (0)
- Su.62. A Clonal Model for Human CD8 Regulatory T Cells: Unrestricted Contact-dependent Killing of Activated CD4 T Cells (2008) (0)
- Acute lymphoblastic leukemia: Use of immune markers in diagnosis, prognosis and therapy (1983) (0)
- Itolizumab, a Novel Targeted Anti-CD6 Therapy, in Combination with Corticosteroids, Is Well-Tolerated, with Rapid Pharmacodynamic and Clinical Response in Newly Diagnosed Acute Graft-Versus-Host Disease (2021) (0)
- Monitoring PD-1 Signaling in Tumor Infiltrating Lymphocytes (2019) (0)
- Enhanced Expression of PD-1 Modulates CD4+Foxp3+ Regulatory T Cell Homeostasis during Low-Dose IL-2 Therapy in Patients with Chronic Graft-Versus-Host Disease (2014) (0)
- PDC-E2, a Common Auto Antigen in Primary Biliary Cirrhosis (PBC) Is Also a Target of an Antibody Response in Patients Who Achieve Complete Remission after Donor Lymphocyte Infusion. (2004) (0)
- A CD4+ T CELL CLONE SELECTED FROM A CML PATIENT AFTER DONOR LYMPHOCYTE INFUSION RECOGNIZES BCR-ABL BREAKPOINT PEPTIDES BUT NOT TUMOR CELLS1 (2001) (0)
- Plasma ST2 Concentrations Predict Development of Acute Gvhd and Non-Relapse Mortality (2012) (0)
- Development and implementation of a computerized system for collection, processing, and administration of cellular therapy products. (2012) (0)
- Cryopreservation of Unrelated Donor Stem Cell Grafts Is Associated with Lower Rates of Chronic Gvhd after Allogeneic Transplantation (2023) (0)
- Comparing the functionality of proleukin® and akron interleukin-2 through an analysis of key T cell subsets (2020) (0)
- Production of Antibodies Targeting Surface Membrane Antigens in Patients with Chronic Graft-Versus-Host Disease and Identification of Targeted Antigens (2017) (0)
- Jerome Ritz Leukemia : Are Patients Living Longer ? Imatinib Therapy for Patients with Chronic Myelogenous (2004) (0)
- Factor VIII Is a Potential Autosomal B Cell Minor Histocompatibility Antigen in Chronic Gvhd. (2009) (0)
- IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo. (2005) (0)
- IDENTIFICATION AND CHARACTERIZATION OF HUMAN LEUKEMIA ASSOCIATED ANTIGENS1 (1985) (0)
- Post-transplant monitoring of erythroid lineage specific chimerism (2006) (0)
- Detection of the NUP214-ABL Rearrangement in T-ALL by High-Density Oligonucleotide Arrays: Evidence of the Value of This Approach in the Identification of Gene Amplifications. (2005) (0)
- Recovery of thymic epithelial cells and immune reconstitution after cord blood transplantation depends on angiogenesis and neovascularization (126.12) (2012) (0)
- Cytokine Profile In Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation (2011) (0)
- phospho-STAT4 protein degradation Specific down-regulation of interleukin-12 signaling through induction of (2013) (0)
- ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION Current issues in chronic graft-versus-host disease (2014) (0)
- Mapping the Evolution of T Cell Transcriptional States during DLI Response and Resistance Using Single-Cell Data (2018) (0)
- P-083: Rejuvenated BCMA-specific CD8+ Cytotoxic T lymphocytes derived from induced pluripotent stem cells for treatment of Multiple Myeloma (2021) (0)
- Enhanced B-Cell Differentiation and Increased Production of Antibodies Targeting Surface Membrane Antigens in Patients with Chronic Graft-Versus-Host Disease (2016) (0)
- Differential Plasma Cytokine Levels in Patients with and without Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (2012) (0)
- Low-Dose IL-2 Therapy Preferentially Improves Diversity of the Regulatory T Cell Repertoire in Patients with Refractory Chronic Graft-Versus-Host Disease (2018) (0)
- Activated Circulating T Follicular Helper Cells with Increased Function during Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation (2015) (0)
- Abstract 6347: Immunotherapeutic application of induced pluripotent stem cell technology: Rejuvenated BCMA-specific CD8+T cells for multiple myeloma (2022) (0)
- Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation (2015) (0)
- An on-going quality improvement project to lower the rate of bacterial contamination in HPC -marrow products (2013) (0)
- Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Outcomes Are Not Impaired in Patients of Advanced Age. (2009) (0)
- Randomized controlled trial of gut decontamination in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (2021) (0)
- Diverse Patterns of T Cell Reactivity Directed against Multiple Y Chromosome-Derived, HLA a*0201 Restricted, Peptides in Patients with chronic Gvhd (2008) (0)
- 2: Identification of Human Minor Histocompatibilty Antigens (mHA) by Combining Bioinformatic Prediction of Peptide Epitopes With Validation of T Cell Reactivity in Patient Blood Samples After Allogeneic Hematopoietic Stem Cell Transplantation (2008) (0)
- Mono clonal antibody to acute leukocytic leukemia associated antigens (1980) (0)
- Developing Novel Approaches To Comprehensively Assess T Cell Repertoire Dynamics In The Early Post-Transplant Period (2013) (0)
- Expansion of a CD8+ Temra Population and Activating T-Cell Interactions Characterize the Graft Versus Leukemia Response in Relapsed AML (2022) (0)
- myelogenous leukemia after allogeneic bone marrow transplantation for chronic Persistence of myeloid progenitor cells expressing BCR-ABL mRNA (2011) (0)
- Increased Proliferation of FoxP3 Regulatory T Cells after Allogeneic Hematopoietic Stem Cell Transplantation Is Counterbalanced by Increased Susceptibility to Apoptosis (2008) (0)
- Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults (2015) (0)
- Interleukin-l 2 Induces Tyrosine Phosphorylation and Activation of 44-kD Mitogen-Activated Protein Kinase in Human T Cells (2002) (0)
- Role of B Cells in Graft-Versus-Leukemia and Graft-Versus-Host Disease (2013) (0)
- Antigene de la leucemie lymphoblastique aigue commune (1988) (0)
- 35: High BAFF and BCR-activated B Cells in Patients with Progressive Chronic Graft Versus Host Disease After Rituximab Treatment (2008) (0)
- 71. Validation of Manufacturing NKG2D Chimeric Antigen Receptor T Cells for a First-In-Human Clinical Trial in AML/MDS and Multiple Myeloma (2016) (0)
- Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab (2020) (0)
- Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity (2021) (0)
- Low Dose IL-2 Therapy in Patients with Chronic Gvhd Induces PD-1+treg That Are Highly Activated, Immune Suppressive, and Proapoptotic (2022) (0)
- Reversal of T Cell Exhaustion in Pre-Treatment Marrow T Cells Is Associated with Effective Graft-Versus-Leukemia Responses to Donor Lymphocyte Infusion (2012) (0)
- childhood acute lymphoblastic leukemia TEL/AML-1 dimerizes and is associated with a favorable outcome in (2011) (0)
- lymphoproliferative disorders post-transplant + Viral induction and targeted inhibition of galectin-1 in EBV (2011) (0)
- Telomerase Activity in Regulatory T Cells is Inversely Associated With Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT) (2011) (0)
- Functional Effects of Low-Dose IL-2 in Patients with Chronic Graft Versus Host Disease (2016) (0)
- Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study (2022) (0)
- age hematopoietic cell transplantation for patients older than 50 years of Comparative outcome of nonmyeloablative and myeloablative allogeneic (2013) (0)
- Gene Expression Profiles of B-lineageAdult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and DistinctMechanisms of Transformation (2005) (0)
- hematopoietic stem cell transplantation Beyond HLA: the significance of genomic variation for allogeneic (2013) (0)
- OR.86. High Frequency CD4+ T‐Cell and Antibody Responses to H-Y Minor Histocompatibility Antigen DBY Following Allogeneic Hematopoietic Stem Cell Transplantation (2006) (0)
- Adoptively Transferred Healthy Donor Treg Expand and Durably Persist in IL-2 Treated Patients with Refractory Chronic GVHD (2021) (0)
- Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL) (2018) (0)
- 361 Cloned human natural killer cells contain serine proteases, carboxypeptidases, and proteoglycans in their secretory granules (1988) (0)
- Expression and Characterization of Leucocyte Antigens (1984) (0)
- Introducing CCR Translations (2008) (0)
- How optimizing efficiency for autologous stem cell collection can set the stage for novel cell therapy growth in multiple departments (2018) (0)
- Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation (2019) (0)
- OR.54. Outcomes of 20 Patients Treated with Anti-CD6-T-cell Depleted, Non-conditioned Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID) including Omenn Syndrome (2008) (0)
- CHAPTER 17: LEUKEMIA (2001) (0)
- transplantation assessment of hematopoietic chimerism after allogeneic stem cell based method for - A novel rapid single nucleotide polymorphism (SNP) (2013) (0)
- Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leukemia Undergoing Myeloablative Allogeneic Transplantation (2019) (0)
- Single Cell T Cell Maps of Donor Lymphocyte Infusion (DLI) Response and Resistance (2019) (0)
- Rejuvenated BCMA-Specific CD8 + Cytotoxic T Lymphocytes Derived from Antigen-Specific Induced Pluripotent Stem Cells : Immunotherapeutic Application in Multiple Myeloma (2021) (0)
- TRANSPLANTATION Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease (2017) (0)
- Safety considerations in the generation of clinical grade autologous ips cell lines (2018) (0)
- BMT Tandem Meetings Best Abstracts (2018) (0)
- Identification of a LOH Region on Chromosome 9p Associated with a Specific Gene Expression Signature in Adult B-Lineage ALL through Integration of High Density Microarray Expression and SNP Analyses. (2004) (0)
- Sequencing-Based Detection of Minimal Residual Disease Is Associated with Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Lymphoid Malignancies (2014) (0)
- Epitope Engineered Hematopoietic Stem and Progenitor Cells to Enable CAR-T Cell Immunotherapy for Acute Myeloid Leukemia (2022) (0)
- Biotherapy Order Entry (BOE) – Electronic Physician Orders for Cellular Therapy Products (2011) (0)
- T-Cell Reconstitution After Hematopoietic Cell Transplantation In Graft-Versus Host Disease Patients (2013) (0)
- Differential Effects of TCR Stimulation and IL-2 On Apoptotic Pathways in CD4 Regulatory T Cells Compared to Conventional CD4 T Cells and CD8 T Cells (2012) (0)
- lymphomas of B-cell and T-cell lineage Expression of common acute lymphoblastic leukemia antigen (CALLA) by (2011) (0)
- Prediction of Severe Acute Graft-Versus-Host Disease (GVHD) in Recipients of HLA Identical Hematopoietic Cell Transplantation (HCT) Using Donor Gene Expression Profiling (2018) (0)
- lymphoblastic leukemia Cell surface antigens: prognostic implications in childhood acute (2011) (0)
- Profiling T Cell Receptor Repertoires in Phase I/II Clinical Trials of Donor Treg Infusion for the Treatment of Chronic Graft-Versus-Host Disease (2018) (0)
- Ineffective erythropoiesis in recipient precursor cells following non-myeloablative stem cell transplantation in patients with severe sickle cell anemia (2004) (0)
- Effects of Daily Low Dose IL-2 Therapy on Homeostatic Regulation of CD4+Foxp3+ Regulatory T Cells In Patients with Chronic Graft-Versus-Host Disease (2010) (0)
- Biomanufacturing for clinically advanced cell therapies (2018) (0)
- Ex vivo quantification of the cooling effect of liver vessels on radiofrequency ablation volume (2009) (0)
- Making Room in the Parking Lot for More Cars - How Changes to Autologous Collection Targets for Patients with Multiple Myeloma Optimized Resource Utilization in the Apheresis Collection Center and Cell Storage Facility at Dana-Farber Cancer Institute (2019) (0)
- Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches. (2005) (0)
- Design of a New Academic GMP Facility for Today and Beyond at the Dana-Farber Cancer Institute (2021) (0)
- phase 2 trial after allogeneic peripheral blood stem cell transplantation: results of a Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD (2014) (0)
- PhosphorylationAugmentation of STAT Serine Kinase and Is Associated with the IL-2 Involves p38 Mitogen-Activated Protein The Functional Synergy Between IL-12 and (1999) (0)
- B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients (2010) (0)
- 5-year performance data and robust flexibility of a computerized physician ordering system for collection, processing, and administration of cellular therapy products (2018) (0)
- Patients Who Respond to Donor Lymphocyte Infusion (DLI) Have an Antibody Response Against PDC-E2, the Immunodominant Autoantigens of Primary Biliary Cirrhosis (PBC), but with Different Specificity. (2005) (0)
- Donor risk factors and recipient clinical impact of positive microbial contamination after bone marrow harvests - a large academic medical center experience (2020) (0)
- 812 Development of BCMA-targeted immunotherapy using vaccine-induced antigen-specific memory CD8+T cells for treating patients with multiple myeloma (2022) (0)
- 332: Effective graft-versus-leukemia responses are associated with the presence of nucleic acid-immunoglobulin complexes that stimulate toll-like receptors (TLR) 8 and 9 (2007) (0)
- 44-kD mitogen-activated protein kinase in human T cells Interleukin-12 induces tyrosine phosphorylation and activation of (2011) (0)
- Prostaglandin E2 (PGE2) Alters the Molecular and Functional Properties of Umbilical Cord Blood T Cells Via Modulating Wnt/β-Catenin Signaling (2012) (0)
- Low Levels of 25-Hydroxyvitamin D Prior to Allogeneic Transplantation Correlate with the Development of Chronic Graft-Versus-Host Disease, (2011) (0)
- Real-World Experience with Low Dose Interleukin-2 for Children with Steroid Refractory Chronic Graft Vs Host Disease (2023) (0)
- RevealingTumor Immunity after Hematopoietic Stem Cell (2009) (0)
- Long-Term Homeostatic Effects of Daily Low-Dose IL-2 on CD4+ FoxP3+ Regulatory T Cells in Patients with Active Chronic Graft-Versus-Host Disease (2015) (0)
- Effective Graft-Versus-Leukemia Responses Are Associated with the Presence of Nucleic Acid-Immunoglobulin Complexes That Stimulate TLR8 and TLR9. (2006) (0)
- Safety And Clinical Efficacy Of Early Vaccination After Nonmyeloablative Transplant For Advanced Chronic Lymphocytic Leukemia (2010) (0)
- Distinct peptide specificities of coordinated T and B cell immune response to DBY minor histocompatibility antigen following allogeneic stem cell transplantation (2003) (0)
- Molecular Remission One Year Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia Predicts Relapse-Free and Overall Survival: A Multi-Institutional Landmark Analysis (2015) (0)
- Inhibiting EZH2 function prevents and treats chronic graft vs host disease (cGVHD) by disrupting germinal center formation and plasma cell maturation (2019) (0)
- Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant (2018) (0)
- Impact of Anti- T Lymphocyte Globulin (ATLG) on Immune Reconstitution in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT): Results From a Prospective Randomized Double Blind Phase 3 Clinical Trial (2017) (0)
- Quantitative CT Square Root Of Wall Area At Pi10 (mm) Correlates With Lung Function And The Development Of Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation (2012) (0)
- Abstract 3682: Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer (2017) (0)
- allogeneic bone marrow transplantation Defective activation of mitogen-activated protein kinase after (2011) (0)
- Rapid Publication Enhancement of Natural Killer Function Through Activation of the TI 1 E Rosette Receptor (2013) (0)
- Impact of White Blood Cell Count Recovery On Clinical Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation (2012) (0)
- receptor associated with antibody response to BCMA, a plasma-cell membrane Graft-versus-tumor response in patients with multiple myeloma is (2013) (0)
- ZAP-70 Expression in Acute Lymphoblastic Leukemia: Association with the E2A/PBX1 Rearrangement and with the Pre-B Stage of Differentiation. (2004) (0)
- Quantitative and Qualitative Immune Reconstitution Following Umbilical Cord Blood Transplantation (2014) (0)
- Low Dose Busulfan Is Associated with Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation. (2012) (0)
- Regulation of Apoptotic Pathways in Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (2013) (0)
- T Cell– and B Cell–Mediated Pathology in Chronic Graft-Versus-Host Disease (2019) (0)
- Expression of α4β7 Integrin on Peripheral Blood Memory CD4+ T-Cells After Allogeneic HCT Correlates with Non-Relapse Mortality and Overall Survival (2012) (0)
- Benoxaprofen and cyproheptadine. (1982) (0)
- IMMU-04. IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL AND ASSESSING CLONAL T CELL RESPONSE (2017) (0)
- associated with antibody responses to highly expressed antigens Complete response to donor lymphocyte infusion in multiple myeloma is (2013) (0)
- SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia (2011) (0)
- B and T cells in chronic graft-versus-host disease and graft-versus-leukemia (2013) (0)
- Reconstitution Of EBV-Specific Immunity In Adult Recipients Of Double Cord Blood Transplantation Depends On SCF and IL-7 Levels and Maintenance Of a Diverse TCR Repertoire (2013) (0)
- Anti-HLA Antibodies Predict Graft Failure, Time to Engraftment and Umbilical Cord Unit Dominance in Double Umbilical Cord Blood Transplantation (2011) (0)
- Cytokine Release Syndrome Severity Following Haploidentical Stem Cell Transplant Is Not Associated with the Measured Cellular Content of Peripheral Blood Stem Cell Grafts (2023) (0)
- Graft-Versus-Leukemia Antigen CML66 Elicits Coordinated B And T Cell Immunity After Donor Lymphocyte Infusion (2010) (0)
- Low Levels of 25-Hydroxyvitamin D Prior to Allogeneic Transplantation Correlate with the Development of Chronic Graft-Versus-Host Disease (2012) (0)
- Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults Depends On Angiogenesis and Neovascularization (2012) (0)
- Cytokine Release Syndrome Post HLA-Mismatched Stem Cell Transplantation Does Not Affect Immune Reconstitution and Is Effectively Treated with Tocilizumab (2022) (0)
- TREG and Tcon Dynamics after Allo-HSCT: Cgvhd Is Associated to Decreased NaïVe and Stem Cell Memory Subsets with a Concomitant Increase in Terminally Differentiated T Cell Subsets (2016) (0)
- Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Phase 2 and Long Term Efficacy, Safety and Immune Correlates (2014) (0)
- Patterns of B Cell Activating Factor (BAFF) Levels, B Cell Recovery, and BAFF/B Cell Ratios Correlate with the Development of Chronic Graft-Versus-Host Disease (cGVHD) Following Hematopoietic Stem Cell Transplantation (HSCT) (2011) (0)
- Post-Transplant Monitoring of Erythroid Lineage Specific Chimerism. (2005) (0)
- cell pool nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T In vivo administration of lymphocyte-specific monoclonal antibodies in (2011) (0)
- Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL) (2019) (0)
- Identification of Novel Antigens with Induced Immune Response in MGUS. (2006) (0)
- 129Enhanced T-cell neogenesis following non-myeloablative adult allogeneic hematopoietic stem cell transplantation (NM-HSCT) (2003) (0)
- at a clonal level In vitro regulation of human hematopoiesis by natural killer cells: analysis (2011) (0)
- Clonal Analysis of Natural Killer Cell Lineage and Function1 (1986) (0)
- Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates (2019) (0)
- Targeting the CD6-Alcam Pathway to Prevent and Treat Graft Vs Host Disease (2020) (0)
- Homeostatic Mechanisms Affect Reconstitution Of CD4+ FoxP3+ Regulatory T Cells After Hematopoietic Stem Cell Transplantation (2009) (0)
- Elevated B cell activating factor (BAFF) in patient plasma after allogeneic stem cell transplantation is a potential biomarker for chronic graft versus host disease (2006) (0)
- Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant (2020) (0)
- Donor Source and Gvhd Prophylaxis Impact Risk of Acute Renal Injury in the Peri-Engraftment Period after Allogeneic Stem Cell Transplantation (2022) (0)
- transplantation in chronic myelogenous leukemia polymerase chain reaction after allogeneic bone marrow Clinical significance of bcr-abl gene rearrangement detected by (2011) (0)
- A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease (2012) (0)
- Chronic graft-versus-host disease (cGVHD) is a life-threatening impediment to allogeneic hematopoietic stem cell transplantation, and current therapies do not completely prevent and/or treat cGVHD. CD4 (2014) (0)
- Expression of CD30 Is Increased on CD8+ T-Cells in Patients with Acute Graft-Vs-Host Disease (2012) (0)
- Editorial: Regulatory T cells in graft versus host disease (2023) (0)
- Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation (2020) (0)
- CD34+CD38− and CD34+HLA−DR− contents in BMSC grafts correlate with short-term engraftment but have no influence on long-term hematopoietic recovery in patients who received autologous bone marrow transplantation (2005) (0)
- TB-03IMMUNOPHENOTYPING OF PEDIATRIC BRAIN TUMORS: CORRELATING IMMUNE INFILTRATE WITH HISTOLOGY, MUTATIONAL LOAD, AND SURVIVAL (2016) (0)
- Development of B-cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma. (2022) (0)
- Mixed Hematopoietic Chimerism for Sickle Cell Disease Prevents Intravascular Hemolysis and Corrects Biomarkers of Endothelial Function. (2005) (0)
- Targeting the Interferon-γ (IFN-γ) Pathway to Enhance Susceptibility of Multiple Myeloma Tumor Cells to NK Cell Lysis (2012) (0)
- Allogeneic B cell response to H-Y minor histocompatibility antigens after donor lymphocyte infusion correlates with disease response (2005) (0)
- Mechanism of EBV inducing anti-tumour immunity and its therapeutic use (2020) (0)
- 271 Maternal lymphocyte engraftment is associated with severe graft versus host disease after haploidentical bone marrow transplantation (1988) (0)
- Constitutive Expression of the High Affinity IL-2 Receptor in a Subpopulation of Resting Peripheral Blood NK Cells (1990) (0)
- transplantation Prostaglandin-modulated umbilical cord blood hematopoietic stem cell (2014) (0)
- Developing a robust competency program for the GMP novel cell therapy laboratory in the cell manipulation core facility laboratory at Dana-Farber Cancer Institute, Boston (2018) (0)
- Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality (2013) (0)
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial (2018) (0)
- Impact of IL-6R Blockade for Cytokine Release Syndrome in Haploidentical Donor Stem Cell Transplant Patients on Infections, Clinical Outcomes and Immune Reconstitution (2020) (0)
- Maintenance of Naïve T Cells and a Diverse TCR Repertoire Are Critical for Reconstitution of EBV-Specific Immunity after Double Cord Blood Transplantation (2014) (0)
- Lower Incidence of Chronic GVHD Observed after Transplantation with Cryopreserved Unrelated Allogeneic Stem Cells. (2023) (0)
- Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ 1 Specific injury and Predicts COVID-19 Severity 2 (2020) (0)
- Chapter 10 Immunity to cancer: Cytotoxic lymphocytes, interleukin-2, and the tumor necrosis factor superfamily (1996) (0)
- Low-Dose Administration of Recombinant IL-2 Following T Cell Depleted Bone Marrow Transplantaion Induces Expansion of CD4+CD25+ FOXP3+ Regulatory T Cells in Vivo. (2004) (0)
- Maturation and Phenotypic Diversity of Human CD4+ Regulatory T Cells in Umbilical Cord Blood and Peripheral Blood from Healthy Donors (2015) (0)
- 181: Identification of Graft-Versus-Myeloma Target Antigens following Syngeneic Hematopoietic Stem Cell Transplantation (2008) (0)
- JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway, (2011) (0)
- Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets (2022) (0)
- Occurrence ofT-Cell Features in a Child's Lymphoproliferative Disorder1 (1984) (0)
- Autologous Whole Tumor Cell Vaccination Early After Allogeneic Stem Cell Transplantation Elicits Anti-Tumor T Cell Responses in Patients with Advanced Chronic Lymphocytic Leukemia (CLL) (2012) (0)
- mpact of Conditioning Regimen Intensity n Outcome of Allogeneic Hematopoietic Cell ransplantation for Advanced Acute Myelogenous eukemia and Myelodysplastic Syndrome (2006) (0)
- TRANSPLANTATION Systematic identi fi cation of personal tumor-speci fi c neoantigens in chronic lymphocytic leukemia (2014) (0)
- Different Human Peripheral Blood Mononuclear Cell Subsets Further Analysis of Interleukin-2 Receptor Subunit Expression on the (2013) (0)
- tumor destruction Protein disulfide isomerases are antibody targets during immune-mediated (2013) (0)
- Immune Reconstitution and Clinical Outcome After Donor Lymphocyte Infusion for Relapsed Disease After Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Diseases Other Than Chronic Myelogenous Leukemia. (2009) (0)
- BK Virus Reactivation After Double Umbilical Cord Blood Transplantation in Adults Correlates with Tregs and Delayed Reconstitution of CD4+ and CD8+ T Effector Cells (2012) (0)
- acute myeloid leukemia cells Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of (2011) (0)
- Genetic Variations in CYP2B6 and Risk of Cyclophosphamide Toxicity in Patients Undergoing Myeloablative Stem Cell Transplantation. (2008) (0)
- Prediction of VOD Using Biomarkers of Endothelial Injury. (2008) (0)
- TRANSPLANTATION Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease (2015) (0)
- Randomized controlled trial of gut decontamination in pediatric patients undergoing allogeneic hematopoietic cell transplantation (2021) (0)
- with commitment to the T-cell receptor alpha beta lineage Disruption of the SCL locus in T-lymphoid malignancies correlates (2011) (0)
- lymphoma Utilization of monoclonal antibodies in the treatment of leukemia and (2011) (0)
- Markers of Angiogenesis and Neovascularization Correlate with Functional Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults (2013) (0)
- Allogeneic B Cell Response to H-Y Minor Histocompatibility Antigens after Donor Lymphocyte Infusion Correlates with Disease Response. (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jerome Ritz?
Jerome Ritz is affiliated with the following schools:
